$40,000 of RESMED CORP. lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to ResMed. Issues related to ResMed. Issues related to ResMed. Issues related to ResMed."
You can find more data on corporate lobbying on Quiver Quantitative.
RMD Insider Trading Activity
RMD insiders have traded $RMD stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $RMD stock by insiders over the last 6 months:
- MICHAEL J. FARRELL (Chairman and CEO) has made 0 purchases and 5 sales selling 24,955 shares for an estimated $5,952,954.
- PETER C FARRELL has made 0 purchases and 4 sales selling 8,000 shares for an estimated $1,970,720.
- BRETT SANDERCOCK (Chief Financial Officer) has made 0 purchases and 3 sales selling 3,000 shares for an estimated $723,090.
- MICHAEL J RIDER (Global General Counsel) has made 0 purchases and 2 sales selling 100 shares for an estimated $25,087.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
RMD Hedge Fund Activity
We have seen 447 institutional investors add shares of RMD stock to their portfolio, and 494 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AMUNDI added 587,872 shares (+123.9%) to their portfolio in Q1 2026, for an estimated $131,965,506
- DIAMANT ASSET MANAGEMENT, INC. added 402,164 shares (+21166.5%) to their portfolio in Q1 2026, for an estimated $90,277,774
- MARSHALL WACE, LLP added 381,296 shares (+inf%) to their portfolio in Q1 2026, for an estimated $85,593,326
- TWO SIGMA INVESTMENTS, LP added 312,468 shares (+inf%) to their portfolio in Q1 2026, for an estimated $70,142,816
- VOLORIDGE INVESTMENT MANAGEMENT, LLC added 309,614 shares (+244.4%) to their portfolio in Q1 2026, for an estimated $69,502,150
- RENAISSANCE TECHNOLOGIES LLC removed 304,480 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $68,349,670
- PRICE T ROWE ASSOCIATES INC /MD/ removed 297,795 shares (-38.7%) from their portfolio in Q1 2026, for an estimated $66,849,021
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
RMD Analyst Ratings
Wall Street analysts have issued reports on $RMD in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 04/15/2026
To track analyst ratings and price targets for RMD, check out Quiver Quantitative's $RMD forecast page.
RMD Price Targets
Multiple analysts have issued price targets for $RMD recently. We have seen 6 analysts offer price targets for $RMD in the last 6 months, with a median target of $272.5.
Here are some recent targets:
- Laura Sutcliffe from Citigroup set a target price of $270.0 on 06/15/2026
- Nathan Treybeck from Wells Fargo set a target price of $227.0 on 05/01/2026
- Craig Wong-Pan from RBC Capital set a target price of $321.0 on 05/01/2026
- Brett Fishbin from Keybanc set a target price of $290.0 on 04/27/2026
- Adam Maeder from Piper Sandler set a target price of $275.0 on 01/30/2026
- Jonathan Block from Stifel set a target price of $265.0 on 01/30/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
